+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
103429-32-9,MFCD00671434
Catalog No.:AA008ROT

103429-32-9 | CTAP

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
1 week  
$347.00   $243.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA008ROT
Chemical Name:
CTAP
CAS Number:
103429-32-9
Molecular Formula:
C51H69N13O11S2
Molecular Weight:
1104.3041
MDL Number:
MFCD00671434
SMILES:
NC(=N)NCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC(C(NC(=O)[C@@H](NC1=O)[C@H](O)C)C(=O)N[C@H](C(=O)N)[C@H](O)C)(C)C)NC(=O)[C@@H](Cc1ccccc1)N)Cc1c[nH]c2c1cccc2
Properties
Computed Properties
 
Complexity:
2060  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
10  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
77  
Hydrogen Bond Acceptor Count:
15  
Hydrogen Bond Donor Count:
15  
Isotope Atom Count:
0  
Rotatable Bond Count:
17  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
-0.1  

Literature

Title: Generation of novel radiolabeled opiates through site-selective iodination.

Journal: Bioorganic & medicinal chemistry letters 20110701

Title: Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors.

Journal: Journal of medicinal chemistry 19881101

Title: Mitchell J Bartlett, et al. Highly-selective µ-opioid Receptor Antagonism Does Not Block L-DOPA-induced Dyskinesia in a Rodent Model.BMC Res Notes

Title: Abbruscato TJ, et al. Blood-brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphine. J Pharmacol Exp Ther. 1997 Jan;280(1):402-9.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 103429-32-9
147159-51-1

147159-51-1

 188627-80-7

188627-80-7

 177943-89-4

177943-89-4

 108736-35-2

108736-35-2

 83150-76-9

83150-76-9

 103429-31-8

103429-31-8
Building Blocks
More >
Historical Records
1326810-44-9

1326810-44-9

 303024-37-5

303024-37-5

 667412-49-9

667412-49-9

 32542-16-8

32542-16-8
Tags:103429-32-9 Molecular Formula|103429-32-9 MDL|103429-32-9 SMILES|103429-32-9 CTAP
Catalog No.: AA008ROT
103429-32-9,MFCD00671434
103429-32-9 | CTAP
Pack Size： 1mg
Purity：
1 week
$347.00 $243.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA008ROT
Chemical Name: CTAP
CAS Number: 103429-32-9
Molecular Formula: C51H69N13O11S2
Molecular Weight: 1104.3041
MDL Number: MFCD00671434
SMILES: NC(=N)NCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC(C(NC(=O)[C@@H](NC1=O)[C@H](O)C)C(=O)N[C@H](C(=O)N)[C@H](O)C)(C)C)NC(=O)[C@@H](Cc1ccccc1)N)Cc1c[nH]c2c1cccc2
Properties
Complexity: 2060  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 10  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 77  
Hydrogen Bond Acceptor Count: 15  
Hydrogen Bond Donor Count: 15  
Isotope Atom Count: 0  
Rotatable Bond Count: 17  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: -0.1  
Literature fold

Title: Generation of novel radiolabeled opiates through site-selective iodination.

Journal: Bioorganic & medicinal chemistry letters20110701

Title: Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors.

Journal: Journal of medicinal chemistry19881101

Title: Mitchell J Bartlett, et al. Highly-selective µ-opioid Receptor Antagonism Does Not Block L-DOPA-induced Dyskinesia in a Rodent Model.BMC Res Notes

Title: Abbruscato TJ, et al. Blood-brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphine. J Pharmacol Exp Ther. 1997 Jan;280(1):402-9.

Related Products of of 103429-32-9
147159-51-1
147159-51-1
188627-80-7
188627-80-7
177943-89-4
177943-89-4
108736-35-2
108736-35-2
83150-76-9
83150-76-9
103429-31-8
103429-31-8
Building Blocks More >
110637-43-9
110637-43-9
Aloc-l-phe-oh dcha
AA008RYD | MFCD04973097
1017789-04-6
1017789-04-6
2-(5-Bromo-pyrimidin-2-yloxy)-benzonitrile
AA008S66 | MFCD09991555
107073-27-8
107073-27-8
3-(Pyrrol-1-yl)thiophene-2-methanol
AA008SF5 | MFCD00052578
1184991-15-8
1184991-15-8
3-KETOVALPROIC ACID SODIUM SALT
AA008SMI | MFCD05864849
1033202-59-3
1033202-59-3
6-Bromo-3-ethyl-3H-imidazo[4,5-b]pyridine
AA008SRB | MFCD08692128
118104-91-9
118104-91-9
1-BUTANOL-1,1,2,2-D4
AA008SXV | MFCD03428310
1202858-68-1
1202858-68-1
1-Bromo-5-isopropoxy-2-methyl-4-nitrobenzene
AA008T69 | MFCD28405053
1017606-66-4
1017606-66-4
Lpa2 antagonist 1
AA008TEM | MFCD28716107
1093659-90-5
1093659-90-5
EZETIMIBE-D4
AA008TJ8 | MFCD08063570
1043554-68-2
1043554-68-2
4-(Piperazin-1-ylsulfonyl)benzoic acid hydrochloride
AA008TN3 | MFCD07687254
Historical Records
1326810-44-9
1326810-44-9
303024-37-5
303024-37-5
667412-49-9
667412-49-9
32542-16-8
32542-16-8
Submit
© 2017 AA BLOCKS, INC. All rights reserved.